Altenburg S P, Bozza P T, Martins M A, Tibiriçá E V, Silva P M, Cordeiro R S, Castro-Faria-Neto H C
Departamento de Fisiologia e Farmacodinâmica, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.
Eur J Pharmacol. 1994 Apr 11;256(1):45-9. doi: 10.1016/0014-2999(94)90614-9.
The involvement of catecholamines in blood neutrophilia observed after administration of platelet activating factor (PAF) to rats was studied. Intravenous (i.v.) injection of PAF (4 micrograms/kg) into naive rats more than doubled the number of neutrophils after 1 h. In contrast, PAF failed to induce neutrophilia in both adrenalectomized rats and those which had their catecholamine stores depleted by reserpine. PAF-induced neutrophilia was not inhibited by the selective antagonism of alpha 1- and alpha 2-adrenoceptors with prazosin and yohimbine, respectively. However, pretreatment with the beta-adrenoceptor antagonist, propranolol, significantly inhibited the phenomenon. Increase in the blood neutrophil counts was also achieved following the i.v. injection of the beta-agonist, salbutamol (1 mg/kg, i.v.). This response was clearly sensitive to propranolol but was not modified in rats submitted to adrenalectomy or reserpine pretreatment. The results suggest that the blood neutrophilia induced by the i.v. administration of PAF in rats is dependent on the stimulation of beta-adrenoceptors by catecholamines released from adrenal glands.
研究了儿茶酚胺在给大鼠注射血小板活化因子(PAF)后出现的血液嗜中性粒细胞增多现象中的作用。向未处理的大鼠静脉注射PAF(4微克/千克),1小时后嗜中性粒细胞数量增加了一倍多。相比之下,PAF在肾上腺切除的大鼠和用利血平耗尽儿茶酚胺储备的大鼠中均未能诱导嗜中性粒细胞增多。分别用哌唑嗪和育亨宾选择性拮抗α1和α2肾上腺素受体,并未抑制PAF诱导的嗜中性粒细胞增多。然而,用β肾上腺素受体拮抗剂普萘洛尔预处理可显著抑制该现象。静脉注射β激动剂沙丁胺醇(1毫克/千克,静脉注射)后,血液嗜中性粒细胞计数也增加。这种反应对普萘洛尔明显敏感,但在接受肾上腺切除或利血平预处理的大鼠中未发生改变。结果表明,静脉注射PAF诱导的大鼠血液嗜中性粒细胞增多依赖于肾上腺释放的儿茶酚胺对β肾上腺素受体的刺激。